The European Centre for Regulatory Affairs Freiburg (EUCRAF) provides the opportunity of a specialized education in the area of biopharmaceutical-related regulatory affairs. It offers seminars and a unique post-graduate Master Programme on biopharmaceutical-related regulatory affairs.
The programme has been developed by distinguished experts from authorities, universities and companies.
EUCRAF’s scientific course committee is composed of experts from universities Freiburg und Strasbourg, from Health Authorities such as the EDQM and the Paul-Ehrlich-Institut, from globally acting companies such as Novartis, Takeda, Pfizer and Roche, biotech companies such as MorphoSys, ATMP-developing companies such as Cellerix and specialists in fields such as drug development and pharmacovigilance.

The Scientific Course Committee

• constantly evaluates the course programme in its practical relevance
• appoints the Study Director and the members of the Admission and Examination Committee
• adopts the Study Regulations, the Guideline on the entry requirements and the Examination Regulations of the course.

Please see here all details on the scientific course committee and its members: more
EUCRAF is independent, does not endorse, recommend or privilege particular companies or establishments, products, services, or technologies.